GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.93 Cr | ₹3.04 Cr | ₹3.04 Cr | ₹3.04 Cr | ₹0.99 Cr |
What is the latest Contingent Liabilities ratio of GRANULES INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹0.93 Cr |
| Mar2025 | ₹3.04 Cr |
| Mar2024 | ₹3.04 Cr |
| Mar2023 | ₹3.04 Cr |
| Mar2022 | ₹0.99 Cr |
How is Contingent Liabilities of GRANULES INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.93 Cr | -69.44 | |
| Mar2025 | ₹3.04 Cr | 0.00 | |
| Mar2024 | ₹3.04 Cr | 0.00 | |
| Mar2023 | ₹3.04 Cr | 206.14 | |
| Mar2022 | ₹0.99 Cr | - | |
Compare Contingent Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹21,619.3 Cr | 4% | -1% | 76.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 4% |
-1% |
76.3% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses